Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma
Companies to form a partnership for cell capture, culture and drug screening for ovarian and breast cancer patients MINNEAPOLIS , Nov. 28, 2017 (GLOBE NEWSWIRE) -- GLG Pharma , a Jupiter, Florida company developing precision medicines that target the Signal Transducer and Activator of Transcription
View HTML
Toggle Summary Skyline Medical and Helomics Corporation Sign Joint Venture Term Sheet to Build-out and Commercialize the D-CHIP™ platform
MINNEAPOLIS , Nov. 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced it has signed a term sheet with Helomics Corporation , a precision
View HTML
Toggle Summary Skyline Medical Reports 2017 Third Quarter Financial Results
MINNEAPOLIS, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Skyline Medical Inc . (NASDAQ:SKLN) ("Skyline" or the "Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, reports financial results for the three and nine months ended September 30, 2017
View HTML
Toggle Summary Uptick Newswire's “Stock Day” News Program Interviews New Proposed Joint Venture Partner of Skyline Medical Inc.
Phoenix, AZ , Nov. 13, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire's "Stock Day" today announced that it has interviewed Gerald Vardzel , CEO of Helomics Corp. , the planned joint venture partner of Skyline Medical (SKLN). Starting off the interview Mr. Vardzel discussed the company’s new key
View HTML
Toggle Summary Skyline Medical to Hold Business Update Conference Call on November 15, 2017
MINNEAPOLIS , Nov. 10, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on November 15 , 2017 
View HTML
Toggle Summary Skyline Medical Inc. Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand
MINNEAPOLIS , Nov. 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced it has partnered with Device Technologies , an established
View HTML
Toggle Summary Skyline Medical Announces Two Proposed Joint Ventures and New Strategic Focus on CRO Services
New collaborations with Helomics and CytoBioscience to diversify Skyline’s operations into the rapidly growing CRO Services sector MINNEAPOLIS , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA -approved STREAMWAY ® System for
View HTML
Toggle Summary Skyline Medical Inc. Expands International Presence by Signing Distribution Agreements in Canada and Switzerland
MINNEAPOLIS , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced it has partnered with two independent distributors to support
View HTML
Toggle Summary Skyline Medical Inc. Enters into Strategic Collaboration with Helomics to Develop Next Generation of Personalized Cancer Diagnostics
MINNEAPOLIS , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, and Helomics Corporation ( Pittsburgh, PA )  have announced a strategic
View HTML
Toggle Summary Skyline Medical to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
MINNEAPOLIS, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, today announced that management will present at the Dawson James Securities 3rd
View HTML